Conference Call with Jubilant Ingrevia Management and Analysts on Q4FY25 & Full Year Performance and Outlook. Listen to the full earnings transcript.
Specialty Chemicals company Jubilant Ingrevia announced Q4FY25 & FY25 results Q4FY25 Financial Highlights: Total Revenue: Rs 1,051 crore in Q4FY25 vs. Rs 1,074 crore in Q4FY24 — down 2% Total EBITDA: Rs 155 crore in Q4FY25 vs. Rs 101 crore in Q4FY24 — up 54% EBITDA Margin (%): 15% in Q4FY25 vs. 9% in Q4FY24 — up 600 bps Profit After Tax (PAT): Rs 74 crore in Q4FY25 vs. Rs 29 crore in Q4FY24 — up 153% PAT Margin (%): 7% in Q4FY25 vs. 3% in Q4FY24 — up 400 bps Basic and Diluted EPS: Rs 4.7 in Q4FY25 vs. Rs 1.8 in Q4FY24 — up 153% FY25 Financial Highlights: Total Revenue: Rs 4,178 crore in FY25 vs. Rs 4,136 crore in FY24 — up 1% Total EBITDA: Rs 557 crore in FY25 vs. Rs 456 crore in FY24 — up 22% EBITDA Margin (%): 13% in FY25 vs. 11% in FY24 — up 200 bps Profit After Tax (PAT): Rs 251 crore in FY25 vs. Rs 183 crore in FY24 — up 37% PAT Margin (%): 6% in FY25 vs. 4% in FY24 — up 200 bps Basic and Diluted EPS: Rs 15.9 in FY25 vs. Rs 11.6 in FY24 — up 37% Result PDF
Conference Call with SRF Ltd. Management and Analysts on Q4FY25 & Full Year Performance and Outlook. Listen to the full earnings transcript.